AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27440189 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based Acceptance and Commitment Therapy (ACT)
Number of subjects: 79
Study 27440189 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 79
Study 25433006 — intervention group
Group type: EXPERIMENTAL
Intervention: Temocillin administered three times daily (6 g daily)
Number of subjects: 32
Study 25433006 — intervention group
Group type: EXPERIMENTAL
Intervention: Temocillin administered by continuous infusion (6 g daily)
Number of subjects: 32
Study 25433006 — intervention group
Group type: EXPERIMENTAL
Intervention: Temocillin administered by continuous infusion (750 mg daily) in patients undergoing CVVH
Number of subjects: 32
Study 24906857 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA)
Number of subjects: 51
Study 24906857 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 51
Study 24906857 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IVTA and IVB
Number of subjects: 51
Study 22391143 — intervention group
Group type: EXPERIMENTAL
Intervention: Small item size cookies
Number of subjects: 77
Study 22391143 — intervention group
Group type: COMPARATOR
Intervention: Large item size cookies
Number of subjects: 77
Study 19296044 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP group (40 mg MBP for 8 months)
Number of subjects: 84
Study 19296044 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk group (8 months)
Number of subjects: 84
Study 19296044 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 19296044 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP group (8 months)
Number of subjects: 84
Study 19296044 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk group (6 months)
Number of subjects: 84
Study 19296044 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk group and MBP group combined
Number of subjects: 84
Study 19296044 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk group and MBP group
Number of subjects: 84
Study 17690800 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms (measured by CES-D)
Number of subjects: 341
Study 15534479 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact-topical anesthesia
Number of subjects: 80
Study 15534479 — intervention group
Group type: COMPARATOR
Intervention: Peribulbar anesthesia
Number of subjects: 80
Study 11575527 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful electrical stimulation (study P)
Number of subjects: 10
Study 11575527 — intervention group
Group type: COMPARATOR
Intervention: No pain (study C)
Number of subjects: 10
Study 9645636 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafcillin sodium in buffered lidocaine
Number of subjects: 790
Study 9645636 — intervention group
Group type: COMPARATOR
Intervention: Placebo (buffered lidocaine hydrochloride)
Number of subjects: 790
Study 8145904 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo infusion (saline placebo)
Number of subjects: 68
Study 3066888 — intervention group
Group type: EXPERIMENTAL
Intervention: Flap with osseous resection surgery (FO)
Number of subjects: 82
Study 3066888 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman surgery (MW)
Number of subjects: 82
Study 3066888 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing (RP)
Number of subjects: 82
Study 3066888 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronal scaling (CS)
Number of subjects: 82
Study 30106252 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-switching performance in healthy individuals with a familial history of psychotic disorder
Number of subjects: 536
Study 30106252 — intervention group
Group type: COMPARATOR
Intervention: Task-switching performance in healthy individuals without a psychiatrically ill relative
Number of subjects: 536
Study 30106252 — intervention group
Group type: COMPARATOR
Intervention: Task-switching performance in individuals with a relative with a mood disorder
Number of subjects: 536
Study 30106252 — intervention group
Group type: COMPARATOR
Intervention: Task-switching performance in individuals with a personal history of depression or anxiety
Number of subjects: 536
Study 30106252 — intervention group
Group type: COMPARATOR
Intervention: Other cognitive control domains (working memory or risk taking)
Number of subjects: 536
Study 27799355 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about harms and addictiveness of waterpipe tobacco smoking (WTS)
Number of subjects: 0
Study 27799355 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no messages)
Number of subjects: 0
Study 26939320 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion (specific acupoints selected based on syndrome differentiation)
Number of subjects: 180
Study 26939320 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen-meridian acupuncture-moxibustion
Number of subjects: 180
Study 26939320 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional western medicine)
Number of subjects: 180
Study 26939320 — intervention group
Group type: COMPARATOR
Intervention: Spleen-meridian group compared to control group
Number of subjects: 180
Study 22998456 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine 0.2% mouthwash
Number of subjects: 30
Study 22998456 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 1% gel
Number of subjects: 30
Study 20926135 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone treatment for CRVO
Number of subjects: 605
Study 20926135 — intervention group
Group type: COMPARATOR
Intervention: Standard Care for BRVO
Number of subjects: 605
Study 20926135 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 605
Study 19735519 — intervention group
Group type: EXPERIMENTAL
Intervention: Juvéderm injectable gel with lidocaine (JUV + L)
Number of subjects: 0
Study 19735519 — intervention group
Group type: COMPARATOR
Intervention: Juvéderm injectable gel without lidocaine (JUV)
Number of subjects: 0
Study 16859530 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular adsorbent recirculating system (MARS)
Number of subjects: 18
Study 16859530 — intervention group
Group type: EXPERIMENTAL
Intervention: Prometheus device
Number of subjects: 18
Study 16859530 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 18
Study 14642152 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (CSEA + PCEA)
Number of subjects: 80
Study 14642152 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (PCIA with tramadol)
Number of subjects: 80
Study 14642152 — intervention group
Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 80
Study 11029829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing elastomerics (Fluor‐I‐Ties and Fluor‐I‐Chain)
Number of subjects: 49
Study 11029829 — intervention group
Group type: COMPARATOR
Intervention: Non fluoride‐releasing elastomerics
Number of subjects: 49
Study 11029829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing elastomerics
Number of subjects: 49
Study 9323649 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk strength measured during maximum isometric and isokinetic exertions
Number of subjects: 20
Study 9323649 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional surfaces of trunk strength
Number of subjects: 20
Study 9323649 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic utilization ratio for trunk muscles
Number of subjects: 20
Study 9323649 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength regressions developed in this study
Number of subjects: 20
Study 8173183 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders to therapy
Number of subjects: 0
Study 8173183 — intervention group
Group type: COMPARATOR
Intervention: Non-responders to therapy
Number of subjects: 0
Study 2944380 — intervention group
Group type: EXPERIMENTAL
Intervention: enprostil (35 micrograms twice daily)
Number of subjects: 21
Study 2944380 — intervention group
Group type: COMPARATOR
Intervention: ranitidine (150 mg twice daily)
Number of subjects: 21
Study 30685500 — intervention group
Group type: COMPARATOR
Intervention: Uva-ursi extract
Number of subjects: 382
Study 30685500 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen advice
Number of subjects: 382
Study 28234983 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-3L
Number of subjects: 199
Study 28234983 — intervention group
Group type: EXPERIMENTAL
Intervention: HUI3
Number of subjects: 199
Study 26669226 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HDs)
Number of subjects: 0
Study 26669226 — intervention group
Group type: COMPARATOR
Intervention: Light drinkers (LDs)
Number of subjects: 0
Study 26669226 — intervention group
Group type: EXPERIMENTAL
Intervention: Han drinkers (HDs and LDs)
Number of subjects: 0
Study 26669226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HDs and LDs
Number of subjects: 0
Study 24224242 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP + irradiation (1-4% O2)
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: Irradiation alone (50 Gy)
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: MAP alone (O2 concentrations between 1 and 15%)
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: No MAP and no irradiation
Number of subjects: 9000
Study 24224242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziploc storage bags (1-4% O2)
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: Xtend PP61 bags (3-8% O2)
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: Xtend PP53 bags (11-15% O2)
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: Irradiation at 150 Gy
Number of subjects: 9000
Study 24224242 — intervention group
Group type: COMPARATOR
Intervention: Irradiation at 100 Gy
Number of subjects: 9000
Study 20809991 — intervention group
Group type: EXPERIMENTAL
Intervention: COMET + regular therapy
Number of subjects: 91
Study 20809991 — intervention group
Group type: COMPARATOR
Intervention: Regular therapy only
Number of subjects: 91
Study 18295622 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional task practice combined with ankle joint mobilizations
Number of subjects: 16
Study 18295622 — intervention group
Group type: COMPARATOR
Intervention: Functional task practice only
Number of subjects: 16
Study 17154748 — intervention group
Group type: EXPERIMENTAL
Intervention: Major Depressive Disorder (MDD)
Number of subjects: 190
Study 17154748 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Affective Disorder (BPAD)
Number of subjects: 190
Study 17154748 — intervention group
Group type: COMPARATOR
Intervention: Both MDD and BPAD
Number of subjects: 190
Study 12540118 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with SuperSnap (SS)
Number of subjects: 64
Study 12540118 — intervention group
Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with SuperSnap (SS)
Number of subjects: 64
Study 12540118 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with CompoSite Polishers (CS)
Number of subjects: 64
Study 12540118 — intervention group
Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with CompoSite Polishers (CS)
Number of subjects: 64
Study 12540118 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with Robot Carbides (RC)
Number of subjects: 64
Study 12540118 — intervention group
Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with Robot Carbides (RC)
Number of subjects: 64
Study 12540118 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with Photac‐Fil Quick (PF)
Number of subjects: 64
Study 12540118 — intervention group
Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with Photac‐Fil Quick (PF)
Number of subjects: 64
Study 11200744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol abusers (group I)
Number of subjects: 220
Study 11200744 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate abusers (group II)
Number of subjects: 220
Study 11200744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol abusers (group I) after 9 days of abstinence
Number of subjects: 220
Study 11200744 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate abusers (group II) after 9 days of abstinence
Number of subjects: 220
Study 11200744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups of dependent patients
Number of subjects: 220
Study 11200744 — intervention group
Group type: COMPARATOR
Intervention: Healthy persons (control group)
Number of subjects: 220
Study 8781922 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (25 Gy in five fractions in one week) followed by operation
Number of subjects: 1168
Study 8781922 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1168
Study 1417537 — intervention group
Group type: EXPERIMENTAL
Intervention: ABO-incompatible group
Number of subjects: 456
Study 1417537 — intervention group
Group type: COMPARATOR
Intervention: ABO-compatible group
Number of subjects: 456
Study 1417537 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive crossmatch group
Number of subjects: 456
Study 1417537 — intervention group
Group type: COMPARATOR
Intervention: Negative crossmatch group
Number of subjects: 456
Study 6716644 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine (3 mg in 1.7 ml physiologic saline solution) administered through the epidural catheter.
Number of subjects: 80
Study 31721979 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (up to 1.8 mg per day)
Number of subjects: 9340
Study 31721979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study 31721979 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340
Study 29787953 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette conditions describing psychiatric disorders (schizophrenia and major depressive disorder)
Number of subjects: 994
Study 27348249 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 2933
Study 27348249 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 2933
Study 24824118 — intervention group
Group type: EXPERIMENTAL
Intervention: LDT monotherapy (600 mg orally, once daily)
Number of subjects: 140
Study 24824118 — intervention group
Group type: EXPERIMENTAL
Intervention: LDT + ADV combination therapy (LDT 600 mg plus ADV 10 mg orally, once daily)
Number of subjects: 140
Study 24824118 — intervention group
Group type: EXPERIMENTAL
Intervention: LDT monotherapy
Number of subjects: 140
Study 24824118 — intervention group
Group type: EXPERIMENTAL
Intervention: LDT + ADV combination therapy
Number of subjects: 140
Study 22895856 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnuts (75 g/day)
Number of subjects: 117
Study 22895856 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet avoiding tree nuts)
Number of subjects: 117
Study 20188583 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 50
Study 20188583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17392302 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty
Number of subjects: 112
Study 17392302 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study 15926717 — intervention group
Group type: EXPERIMENTAL
Intervention: Paradoxical temporal lobe epilepsy (PTLE) group
Number of subjects: 12
Study 15926717 — intervention group
Group type: COMPARATOR
Intervention: Medial temporal sclerosis (MTS) group
Number of subjects: 12
Study 15926717 — intervention group
Group type: EXPERIMENTAL
Intervention: PTLE group
Number of subjects: 12
Study 15926717 — intervention group
Group type: COMPARATOR
Intervention: MTS group
Number of subjects: 12
Study 12198063 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen (500 mg)
Number of subjects: 80
Study 12198063 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 80
Study 11500654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sagittal split ramus osteotomy
Number of subjects: 40
Study 11500654 — intervention group
Group type: EXPERIMENTAL
Intervention: Total mandibular subapical alveolar osteotomy
Number of subjects: 40
Study 9699932 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 MU of reteplase (Group A)
Number of subjects: 142
Study 9699932 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 MU of reteplase (Group B)
Number of subjects: 142
Study 9699932 — intervention group
Group type: COMPARATOR
Intervention: Bleeding complications
Number of subjects: 142
Study 9699932 — intervention group
Group type: COMPARATOR
Intervention: Coronary patency
Number of subjects: 142
Study 7877158 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized reactivity assessments with randomized order of resting and reactivity measurements
Number of subjects: 451
Study 7877158 — intervention group
Group type: COMPARATOR
Intervention: Standardized reactivity assessments
Number of subjects: 451
Study 3266005 — intervention group
Group type: EXPERIMENTAL
Intervention: HbOC (Haemophilus influenzae type b mutant-diphtheria toxic conjugate vaccine)
Number of subjects: 51
Study 3266005 — intervention group
Group type: EXPERIMENTAL
Intervention: HbOC (after second dose at 4 months)
Number of subjects: 51
Study 3266005 — intervention group
Group type: EXPERIMENTAL
Intervention: HbOC (after third dose at 6 months)
Number of subjects: 51
Study 3266005 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined passive/active immunization (HbOC and bacterial polysaccharide immunoglobulin) at 2 months
Number of subjects: 51
Study 30213449 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg oral per day) plus androgen deprivation therapy
Number of subjects: 1207
Study 30213449 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus androgen deprivation therapy
Number of subjects: 1207
Study 28818054 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor pollicis muscle acceleromyography
Number of subjects: 60
Study 28818054 — intervention group
Group type: COMPARATOR
Intervention: Trapezius muscle acceleromyography
Number of subjects: 60
Study 28818054 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.3 mg/kg IV
Number of subjects: 60
Study 26202168 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato soup (2-2¾ cups prepared/d)
Number of subjects: 33
Study 26202168 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato sauce (142-198 g/d or 5-7 ounces/d)
Number of subjects: 33
Study 26202168 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable juice (325-488 ml/d or 11-16.5 fluid ounces/d)
Number of subjects: 33
Study 26202168 — intervention group
Group type: COMPARATOR
Intervention: Lycopene-restricted control group (< 5 mg lycopene/d)
Number of subjects: 33
Study 24286114 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB) 4.5 g/night (administered in 2 equally divided doses), with possible increases to 9 g/night or reductions to 4.5 g/night.
Number of subjects: 560
Study 21384334 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of adjuvanted influenza A/09/H1N1 vaccine in patients with inflammatory rheumatic diseases
Number of subjects: 173
Study 21384334 — intervention group
Group type: COMPARATOR
Intervention: One dose of adjuvanted influenza A/09/H1N1 vaccine in healthy controls
Number of subjects: 173
Study 21384334 — intervention group
Group type: COMPARATOR
Intervention: Baseline antibody levels in patients and controls
Number of subjects: 173
Study 21384334 — intervention group
Group type: EXPERIMENTAL
Intervention: First dose response in both groups
Number of subjects: 173
Study 17957120 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilised form of B. animalis DN‐173 010
Number of subjects: 12
Study 17957120 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented product of B. animalis DN‐173 010
Number of subjects: 12
Study 17957120 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 12
Study 16616012 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (585 mg of docosahexaenoic acid and 225 mg of eicosapentaenoic acid)
Number of subjects: 18
Study 16616012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 14651731 — intervention group
Group type: EXPERIMENTAL
Intervention: Belladonna 30C
Number of subjects: 253
Study 14651731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 10836774 — intervention group
Group type: EXPERIMENTAL
Intervention: Debriefing interview group
Number of subjects: 132
Study 10836774 — intervention group
Group type: COMPARATOR
Intervention: Observation-only group
Number of subjects: 132
Study 8839521 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) 10 to 15 micrograms/kg
Number of subjects: 40
Study 8839521 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular meperidine, promethazine, and chlorpromazine (MPC) 2 mg/kg meperidine, 0.5 mg/kg promethazine, 0.5 mg/kg chlorpromazine
Number of subjects: 40
Study 8839521 — intervention group
Group type: EXPERIMENTAL
Intervention: OTFC
Number of subjects: 40
Study 8839521 — intervention group
Group type: COMPARATOR
Intervention: MPC
Number of subjects: 40
Study 8839521 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 1610630 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml kg‐1 of 4% glucose and 0.18% saline (group II)
Number of subjects: 30
Study 1610630 — intervention group
Group type: COMPARATOR
Intervention: No preoperative fluid (group I)
Number of subjects: 30
Study 1610630 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (I and II)
Number of subjects: 30
Study 30735532 — intervention group
Group type: EXPERIMENTAL
Intervention: High social deprivation
Number of subjects: 6768
Study 30735532 — intervention group
Group type: COMPARATOR
Intervention: Low social deprivation
Number of subjects: 6768
Study 29641584 — intervention group
Group type: EXPERIMENTAL
Intervention: Revealed identity of the receiver
Number of subjects: 632
Study 29641584 — intervention group
Group type: COMPARATOR
Intervention: Anonymous ultimatum game
Number of subjects: 632